In this cohort study of 57 278 adults, addition of short-acting insulin was associated with increased all-cause mortality compared with long-acting insulin alone and a decreased risk of acute myocardial infarction, with limited evidence of a difference in congestive heart failure. Here, INS is linked to acute myocardial infarction.